HTG Molecular Diagnostics to Publicly Offer Shares

HTG Molecular Diagnostics announced recently after the close of the market that it intends to offer an undisclosed amount of its common stock in a public offering. 
 
The Tucson, Arizona-based diagnostics firm did not price its offering. 
 
Cantor Fitzgerald is the sole book-running manager for the offering. HTG expects to grant the underwriter a 30-day option to purchase additional shares of its common stock at the public offering price. 
 
The company had $11.8 million in cash and cash equivalents and $9.8 million in short-term investments as of June 30, it said during its second quarter earningsannouncements last month.